Table 3.
Sofosbuvir–velpatasvir 12 weeks N = 51 | Sofosbuvir–velpatasvir plus ribavirin 12 weeks N = 51 | |
---|---|---|
Overall SVR12 | 47/51 (92) | 47/51 (92) |
Genotype | ||
1a | 0/1 (0) | – |
1b | 39/40 (98) | 35/39 (90) |
2 | 8/9 (89) | 12/12 (100)a |
3 | 0/1 (0) | – |
Baseline CPT class | ||
A | 1/1 (100) | 2/2 (100) |
B | 38/40 (95) | 38/39 (97) |
C | 8/10 (80) | 7/10 (70) |
aIncludes 1 patient who was initially categorized as missing HCV genotype, and subsequently determined to have genotype 2a by BLAST analysis